Market Research Logo

Global Allergy Rhinitis Drugs Market 2017-2021

Global Allergy Rhinitis Drugs Market 2017-2021

About Allergy Rhinitis Drugs

Allergic rhinitis refers to the inflammation of nasal membranes that causes nasal congestion, sneezing, itching, and rhinorrhea. This condition is usually caused by dust, animal dander, pollen, and certain food ingredients. Allergic rhinitis or hay fever occurs when the immune system overreacts to allergens in the air such as dust, animal dander, or pollen. Symptoms can also occur due to various food allergies.

Technavio’s analysts forecast the global allergy rhinitis drugs market to grow at a CAGR of 3.05% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global allergy rhinitis drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Allergy Rhinitis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • GlaxoSmithKline
  • Sanofi
  • ALK-Abelló
  • Meda Pharmaceuticals
Other prominent vendors
  • Adamis Pharmaceuticals
  • Allergy Therapeutics
  • Almirall
  • Ampio
  • AstraZeneca
  • Amneal Pharmaceuticals
  • Anergis
  • Apotex
  • Array BioPharma
  • Aspen Pharmacare
  • Circassia Pharmaceuticals
  • Dr Reddy's Laboratories
  • Eddingpharm
  • EMS
  • HAL Allergy
  • Inmunotek
  • Genentech
  • Greer Laboratories
  • Glenmark Pharmaceuticals
  • Hanmi Pharmaceuticals
  • Hisamitsu Pharmaceutical
  • Intas Pharmaceuticals
  • Novartis
  • Nuvo Research
  • Nycomed
  • Omega Pharma
  • Shionogi
  • Stallergenes
  • Sun Pharmaceuticals
  • Takeda
  • Teva Pharmaceuticals
  • Verona Pharma
  • VentiRx Pharmaceuticals
Market driver
  • Increasing awareness about allergic rhinitis
  • For a full, detailed list, view our report
Market challenge
  • Patent expiries and generic competition
  • For a full, detailed list, view our report
Market trend
  • Increase in R&D activities
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Allergy Rhinitis Drugs Market 2017-2021

Technavio recognizes the following companies as the key players in the global allergy rhinitis drugs market: GlaxoSmithKline, Sanofi, ALK-Abelló and Meda Pharmaceuticals.

Other Prominent Vendors in the market are: Adamis Pharmaceuticals, Allergy Therapeutics, Almirall, Ampio, AstraZeneca, Amneal Pharmaceuticals, Anergis, Apotex, Array BioPharma, Aspen Pharmacare, Circassia Pharmaceuticals, Dr Reddy's Laboratories, Eddingpharm, EMS, HAL Allergy, Inmunotek, Genentech, Greer Laboratories, Glenmark Pharmaceuticals, Hanmi Pharmaceuticals, Hisamitsu Pharmaceutical, Intas Pharmaceuticals, Novartis, Nuvo Research, Nycomed, Omega Pharma, Shionogi, Stallergenes, Sun Pharmaceuticals, Takeda, Teva Pharmaceuticals, Verona Pharma and VentiRx Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increase in R&D activities. Allergic diseases are one of the fastest-growing chronic diseases globally. If not managed properly at an early stage, allergic diseases such as rhinitis can increase the risk of asthma in the later stage of life. Several organizations around the world work to better understand the pathogenesis of allergic diseases.”

According to the report, one driver in the market is increasing awareness about allergic rhinitis. The increasing awareness about allergic rhinitis is fueling the market growth. Due to various environmental factors, the prevalence of allergic rhinitis is increasing in US. In the US, awareness programs and initiatives are undertaken by various organizations to spread disease awareness among the target population. Asthma and Allergy Foundation of America (AAFA) observes May as the National Asthma and Allergy Awareness Month and April is observed as the Allergic Rhinitis Awareness Month. The organization conducts several events such as fundraising programs, conferences, and online events.

Further, the report states that one challenge in the market is patent expiries and generic competition. The patent expiry of major drugs approved for allergy rhinitis is expected to adversely affect the market and slow down its growth during the forecast period. The patent expiry of a drug often results in the loss of the exclusive market, leading to a rapid decline in sales. Drugs that lose patent protection become open to generic competition. Generics have been gathering an increasing share of the market for allergy rhinitis drugs.

Companies Mentioned

GlaxoSmithKline, Sanofi, ALK-Abelló, Meda Pharmaceuticals, Adamis Pharmaceuticals, Allergy Therapeutics, Almirall, Ampio, AstraZeneca, Amneal Pharmaceuticals, Anergis, Apotex, Array BioPharma, Aspen Pharmacare, Circassia Pharmaceuticals, Dr Reddy's Laboratories, Eddingpharm, EMS, HAL Allergy, Inmunotek, Genentech, Greer Laboratories, Glenmark Pharmaceuticals, Hanmi Pharmaceuticals, Hisamitsu Pharmaceutical, Intas Pharmaceuticals, Novartis, Nuvo Research, Nycomed, Omega Pharma, Shionogi, Stallergenes, Sun Pharmaceuticals, Takeda, Teva Pharmaceuticals, Verona Pharma and VentiRx Pharmaceuticals.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Types of allergic rhinitis
      • Table Risk factors associated with allergic rhinitis
  • Pipeline Landscape
    • Table Key pipeline candidates by vendor and number of drugs
    • Table Pipeline analysis
  • Market landscape
    • Market overview
      • Table Global allergy rhinitis drugs market snapshot
      • Table Global allergy rhinitis drugs market 2016-2021 ($ millions)
      • Table Five forces analysis
  • Market segmentation by drug class
    • Table Global allergy rhinitis drugs market: Segmentation by drug class
    • Global allergy rhinitis antihistamines market
      • Table Global allergy rhinitis antihistamines market 2016-2021 ($ millions)
    • Global allergy rhinitis intranasal corticosteroids market
      • Table Global allergy rhinitis intranasal corticosteroids market 2016-2021 ($ millions)
    • Global allergy rhinitis immunotherapies market
      • Table Global allergic rhinitis immunotherapies market 2016-2021 ($ millions)
    • Others
  • Geographical segmentation
    • Table Global allergy rhinitis drugs market by geography 2016 and 2021
    • Table Global allergy rhinitis drugs market revenue by geography 2016-2021 ($ millions)
    • Allergy rhinitis drugs market in Americas
      • Table Market scenario in Americas
      • Table Allergy rhinitis drugs market in Americas ($ millions)
    • Allergy rhinitis drugs market in EMEA
      • Table Market scenario in EMEA
      • Table Allergy rhinitis drugs market in EMEA 2016-2021 ($ millions)
    • Allergy rhinitis drugs market in APAC
      • Table Market scenario in APAC
      • Table Allergy rhinitis drugs market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Strategic alliances
    • Increase in R&D activities
    • Self-medication using OTC products
      • Table Drugs that underwent prescription-to-OTC switch in the US
  • Vendor Landscape
    • Competitive landscape
      • Table Competitive structure analysis of global allergy rhinitis drugs market 2016
  • Vendor landscape
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: Strategy assessment
      • Table Sanofi: Opportunity assessment
    • ALK-Abelló
      • Table ALK-Abelló: Key highlights
      • Table ALK-Abelló: Strength assessment
      • Table ALK-Abelló: Strategy assessment
      • Table ALK-Abelló: Opportunity assessment
    • Meda Pharmaceuticals
      • Table Meda Pharmaceuticals: Key highlights
      • Table Meda Pharmaceuticals: Strength assessment
      • Table Meda: Strategy assessment
      • Table Meda: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report